pharmaphorum

MAY 27, 2022

This is the second in a two-part series examining how pharma can embrace the DEI agenda to create more effective medicines through more representative clinical trials. The same principles are increasingly being applied to clinical trials to improve diversity, mitigate bias, and reinforce inclusion in clinical trials.

Clinical Trials 80

Clinical Trials Clinical Trials Trials Packaging 80

pharmaphorum

FEBRUARY 11, 2021

Pharma companies face many challenges when involving patients in the design of clinical trials – but doing so can have huge benefits further down the line, improving the sustainability and quality of research. Designing better trials. Involving patients in discussions.

Clinical Trials 101

Clinical Trials Clinical Trials Trials Clinical Research 101

pharmaphorum

MAY 20, 2022

Last year, the company added clinical trials to the list with the launch of CVS Health Clinical Trial Services , an initiative that works with pharma companies on clinical trial recruitment and even hosts trial sites at certain retail locations. Why is that now important for clinical research?

Clinical Trials 90

Clinical Trials Clinical Trials Trials Clinical Research 90

Find Me Cure

SEPTEMBER 2, 2020

As part of our patient advocacy efforts, at FindMeCure we are dedicated to creating a bridge between patients and the world of clinical research. This includes spreading clinical trial awareness, connecting patients to the trials they are interested in but also speaking up about the issues in the clinical research industry. .

Clinical Research 97

Clinical Research Research Clinical Trials Clinical Trials 97

Pharmaceutical Technology

MARCH 30, 2023

The US FDA has revealed its detailed budget proposal for FY2024, which would require pharma companies to name their active pharmaceutical ingredient (API) suppliers, restart President Biden’s Cancer Moonshot, inject cash into amyotrophic lateral sclerosis (ALS) research, and enforce stricter rules around manufacturing, recalls, and shortages.

Contract Manufacturing 147

Contract Manufacturing Manufacturing Pharma Companies Cosmetics 147

pharmaphorum

JULY 14, 2022

A pilot study has been launched by the EMA to see whether it is helpful for regulators to look at the ‘raw data’ from clinical trials submitted in support of new marketing application along with the usual structured analyses from sponsors. It may also help the regulator to define target treatment populations better.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Regulation 52

WCG Clinical

JUNE 4, 2024

You said something very important to rare disease families, which is that you have an initiative going to focus on the collection of natural history data and its use, something very important to change the nature of rare disease research for the better. Initially, I was really hoping we would have a far a pharma partner by now.

Research 52

Research Clinical Trials Clinical Trials Doctors 52

pharmaphorum

NOVEMBER 4, 2020

Since then the story of Alzheimer’s research has been one of expensive failures as experimental drugs, mainly targeting the amyloid plaques found in the brains of people with the disease, failed to stop or slow cognitive decline in clinical trials.

Trials 74

Trials Drugs Bacteria Pharma Companies 74

XTalks

MAY 11, 2023

Clinical trials are essential for the development of new treatments for rare diseases, but they can be complex and challenging to execute. Patient input is a crucial component of rare disease clinical trials, as it can provide valuable insights into the patient experience and inform decisions about study design and implementation.

Clinical Trials 97

Clinical Trials Clinical Trials Trials Development 97

XTalks

MAY 6, 2022

In this interview, Xtalks spoke with experts from eClinical Solutions , Katrina Rice, Chief Delivery Officer, Data Services; and Diane Lacroix, Vice President, Clinical Data Management, about clinical data management for modern day digital clinical trials. Clinical trials aim to see whether a new investigational drug is safe and effective.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Life Science 98

Pharmaceutical Technology

JANUARY 31, 2023

FDA director Robert Califf gave his prognosis for the pharma industry at this year’s JP Morgan Healthcare Conference in San Francisco over January 9–12. That leaves three years for pharma companies to prepare. asked panel chair Ipsita Smolinski, MD of consultancy Capitol Street. It’s much needed. It’s a hot area.”

Drugs 130

Drugs Regulation Gene Therapy Insulin 130

pharmaphorum

FEBRUARY 14, 2022

According to Deloitte, this can be attributed to the increase in the number of assets in the late stage pipeline of the companies studied, which saw an average of 16.1 assets per company in later stages of development.

Production 98

Production Clinical Trials Clinical Trials Sales 98

Pharmaceutical Technology

DECEMBER 21, 2022

But as the field grows in leaps and bounds, many authorities have prioritised the release of new guidelines, frameworks, and regulations to keep pace with these advances. According to a cross-sectorial survey by the consulting firm Mckinsey & Company , 52% of respondents reported investing in AI this year compared to 40% in 2018.

Regulation 351

Regulation Pharma Companies Medicine Clinical Trials 351

pharmaphorum

AUGUST 21, 2020

Pfizer and BioNTech have said their COVID-19 vaccine could be ready for regulators to review by October and approved by the end of the year after releasing more favourable data from an early-stage trial. Could AI prevent future pandemics by developing an armoury of drugs that work against all coronaviruses?

Vaccination 106

Vaccination Vaccine Regulation Manufacturing 106

Placebo Control

JULY 31, 2013

Ben Goldacre has rather famously described the clinical trial reporting requirements in the Food and Drug Administration Amendments Act of 2007 as a “ fake fix ” that was being thoroughly “ignored” by the pharmaceutical industry. Pharma: breaking the law in broad daylight?

Pharma Companies 40

Pharma Companies Trials Compliance Clinical Trials 40

pharmaphorum

JULY 5, 2021

billion to claim ownership of the contract research organisation. The handover comes four years after Pamplona Capital Management bought the company for around $5 billion, and just a few weeks after lab tech company Thermo Fisher Scientific agreed to acquire another CRO – PPD – in a deal valued at $17.4

Clinical Trials 65

Clinical Trials Clinical Trials Regulation Trials 65

XTalks

SEPTEMBER 5, 2023

With over two decades of experience in vaccine research, Boceta-Muñoz has experience across all clinical development phases in a range of therapeutic areas. Investigation of the possibility of VAED is crucial during clinical trials for decision-making on vaccine licensing by regulatory agencies.

Vaccination 96

Vaccination Vaccine Development Clinical Trials 96

pharmaphorum

AUGUST 31, 2021

For the healthcare ecosystem to drive research and care, clarity is needed about the opportunities and challenges of ECAs and their value in bringing therapies to patients faster, say COTA Viraj Narayanan and Karla Feghali from ConvergeHEALTH by Deloitte. Myth 2: Implementing an ECA requires too much money, time and resource.

Clinical Trials 89

Clinical Trials Clinical Trials Life Science Trials 89

XTalks

FEBRUARY 15, 2024

US Senator Bernie Sanders, who chairs the Health, Education, Labor, and Pensions (HELP) Committee, managed to bring CEOs of major American pharma companies to a committee hearing to discuss exorbitant US drug pricing. PBMs aren’t doing a single bit of research. Senator Tim Kaine, D-Virginia, echoed the PBM talking point. “We

Drugs 52

Drugs Pharma Companies Pharmacy Regulation 52

pharmaphorum

JUNE 14, 2021

Rebecca Sanders from Lipodystrophy UK tells us how the patient voice helped convince NICE to approve a much-needed drug for this rare disease, and explores how regulators and pharma companies can help make patient involvement in HTA more impactful. This article appears in our free digital magazine Deep Dive: Market Access 2021.

Drugs 105

Drugs Pharma Companies Licensing Licensing 105

pharmaphorum

FEBRUARY 18, 2021

Researchers from the University of Texas Medical Branch based their findings on lab tests using SARS-CoV-2 coronaviruses that were genetically engineered to have the same mutations as those in the strain that is causing scientists so much concern.

Immune Response 52

Immune Response Genetic Engineering Vaccination Vaccine 52

XTalks

MARCH 28, 2024

Bettica said the company’s focus is to now “make Duvyzat available as a treatment for DMD management in the US as quickly as possible.” The study is one of the largest DMD Phase III trials to date. Participants received Duvyzat twice daily or placebo in addition to glucocorticosteroid treatment.

FDA Approval 105

FDA Approval Genetics Gene Therapy Gene 105

Drug Discovery World

MAY 6, 2024

billion on R&D during 2021, with Germany and Switzerland being the biggest contributors, and around one fourth of clinical trials worldwide were performed in Europe 1. The city is host to many innovative biotech companies, including relative newcomers Orexa, a company that recently launched its first Phase II clinical trial.

Drugs 59

Drugs Life Science Gene Editing Gene 59

pharmaphorum

OCTOBER 28, 2020

Claus Møldrup explores research showing that patients want their voice to be heard more by pharma, and asks what a truly effective feedback loop for medicines might look like. Pharma remains stubbornly closed to feedback, with potentially damaging consequences for the industry, healthcare systems and patients. The way back.

Medicine 120

Medicine Pharma Companies Vaccination Vaccine 120

Drug Discovery World

DECEMBER 27, 2023

Ng is working on critical challenges in clinical trials, specifically in planning and recruitment, and has been building innovative solutions designed to benefit patients and researchers – with a focus on efficiency, transparency and diversity in clinical development. Listen here. Listen here. Listen here.

Clinical Trials 69

Clinical Trials Clinical Trials Drugs Development 69

Drug Discovery World

FEBRUARY 6, 2024

As AI-designed drugs start to enter large-scale clinical trials, DDW’s Diana Spencer investigates how new digital tools are reinventing and reshaping drug discovery for the future. Universities are also using these digital technologies to advance their research.

Marketing 69

Marketing Medicine Genome Genomics 69

Drug Discovery World

SEPTEMBER 28, 2022

Its application in pharma, most commonly in drug discovery, has been steadily growing with global partnerships between tech vendors and pharma companies becoming more commonplace. According to Hampleton Patners’ latest Healthtech M&A market report2, digital health companies raised a total of $57.2

Pharma Companies 52

Pharma Companies Drugs In-Vivo Genetics 52

pharmaphorum

SEPTEMBER 7, 2020

High barriers to entering the sector and high levels of regulation are just two factors that have meant that there has often been an “innovation lag” when it comes to implementing new technologies and embracing technological and digital change in the pharma industry. Enhancing the clinical trials process.

Clinical Trials 125

Clinical Trials Clinical Trials Trials Marketing 125

Cloudbyz

MAY 19, 2021

The industry marked abundant gene-therapy-related activities, testing, and trials all well funded and financially supported by an influx of angel investors and venture capitalists. billion in 2030 (Source: the business research compan y). billion in 2020 and is further expected to reach $34.31

Gene Therapy 52

Gene Therapy Gene Manufacturing Production 52

Advarra

JULY 19, 2022

The sponsor is the pharmaceutical company conducting the trial. If you mean using a different contract research organization (CRO) for the different phases of clinical trials – that’s different. Also consider CRO oversight, trial management, data handling and record keeping, as well as allocation of responsibilities.

Packaging 52

Packaging Packaging Drugs Containment 52

pharmaphorum

MARCH 12, 2021

COVID-19 has transformed the way we think about patient participation in trial design – but there are still many barriers to overcome in improving engagement. Speakers at the NIHR’s recent virtual event for the pharma industry discussed best practices for bringing patient insights into research.

Trials 132

Trials Research Pharma Companies Clinical Trials 132

pharmaphorum

APRIL 28, 2022

Although they have, by definition, small addressable markets, the treatments cost just as many resources to develop as therapies for more common diseases – sometimes more, because of the added difficulty of finding sufficiently large patient populations for trials and finding disease experts to run them. How big pharma tackles rare diseases.

Pharma Companies 59

Pharma Companies Branding Development Marketing 59

XTalks

DECEMBER 29, 2022

In 2022 alone, the US regulator approved four new gene therapies, showing the high interest in getting these therapies to market. It has also been granted Regenerative Medicine Advanced Therapy (RMAT), Fast Track, Orphan Drug, and Rare Pediatric Disease designations from the US regulator for both SCD and TDT.

Life Science 52

Life Science Gene Therapy Gene Manufacturing 52

pharmaphorum

JANUARY 29, 2021

California-based Sangamo Therapeutics is one such company that believes in the powerful potential of in vivo genome editing and regulation, together known as genome engineering, and has built up a sizable preclinical pipeline of genome regulation treatments for diseases such as Huntington’s disease and Amyotrophic lateral sclerosis (ALS).

Gene Editing 145

Gene Editing Gene Gene Therapy In-Vivo 145

pharmaphorum

JUNE 8, 2021

Dr Jay Mei from Antengene tells us how the Asia Pacific region is opening up to innovative pharma companies, and gives tips for companies navigating this enormous market. At the same time, lots of people with experience at multinational pharmaceutical companies have chosen to return home. About the interviewee.

Marketing 106

Marketing Drugs Regulation Development 106

Drug Discovery World

APRIL 20, 2023

Regulators are therefore used to seeing cognitive data as primary or secondary outcomes in clinical trials, and are familiar with the instruments and methodological nuances of such data. Dr Paula Moran is a pioneering research scientist and an honorary Associate Professor at the University of Nottingham. depression).

Development 98

Development Drugs Clinical Trials Clinical Trials 98

Delveinsight

FEBRUARY 14, 2021

Developing a new drug requires years of research, time, and money; and in cases where winds are against the market forces and profit margins appear shallow, conducting and bearing the cost for such trials can prove to be a pretty penny. Conducting clinical trials for rare diseases? Aftermath of clinical trials.

Marketing 52

Marketing Clinical Trials Clinical Trials Trials 52